ClearPoint Neuro Inc (CLPT)
11.84
+0.74
(+6.72%)
USD |
NASDAQ |
Nov 22, 16:00
11.83
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Revenue (TTM): 30.43M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 30.43M |
June 30, 2024 | 28.07M |
March 31, 2024 | 26.16M |
December 31, 2023 | 23.96M |
September 30, 2023 | 22.32M |
June 30, 2023 | 21.70M |
March 31, 2023 | 20.95M |
December 31, 2022 | 20.55M |
September 30, 2022 | 19.66M |
June 30, 2022 | 19.09M |
March 31, 2022 | 17.30M |
December 31, 2021 | 16.30M |
September 30, 2021 | 15.73M |
June 30, 2021 | 14.68M |
March 31, 2021 | 13.74M |
December 31, 2020 | 12.83M |
September 30, 2020 | 12.32M |
June 30, 2020 | 11.73M |
March 31, 2020 | 11.86M |
December 31, 2019 | 11.22M |
September 30, 2019 | 10.28M |
June 30, 2019 | 9.162M |
March 31, 2019 | 8.202M |
December 31, 2018 | 7.353M |
September 30, 2018 | 6.756M |
Date | Value |
---|---|
June 30, 2018 | 6.666M |
March 31, 2018 | 6.996M |
December 31, 2017 | 7.380M |
September 30, 2017 | 7.335M |
June 30, 2017 | 7.234M |
March 31, 2017 | 6.362M |
December 31, 2016 | 5.750M |
September 30, 2016 | 5.626M |
June 30, 2016 | 5.256M |
March 31, 2016 | 4.978M |
December 31, 2015 | 4.594M |
September 30, 2015 | 4.042M |
June 30, 2015 | 3.429M |
March 31, 2015 | 3.792M |
December 31, 2014 | 3.604M |
September 30, 2014 | 3.821M |
June 30, 2014 | 4.115M |
March 31, 2014 | 3.489M |
December 31, 2013 | 3.931M |
September 30, 2013 | 4.617M |
June 30, 2013 | 4.821M |
March 31, 2013 | 5.342M |
December 31, 2012 | 5.058M |
September 30, 2012 | 4.360M |
June 30, 2012 | 4.383M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
11.22M
Minimum
Dec 2019
30.43M
Maximum
Sep 2024
18.53M
Average
18.19M
Median
Revenue (TTM) Benchmarks
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 38.27M |
InfuSystems Holdings Inc | 132.78M |
Xtant Medical Holdings Inc | 113.86M |
Catheter Precision Inc | 0.399M |